SCHEMBL25586552

SCHEMBL25586552

Cn1c(Cc2ccccc2)nnc1C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.49
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.47
APOBEC3A P31941 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
MEN1 O00255 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
PLA2G10 O15496 1/20 0.45
PLA2G2A P14555 1/20 0.45
LMNA P02545 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
TYK2 P29597 1/20 0.42
JAK3 P52333 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25586090 0.85 HDAC6 (0.51) PKMALDH1A1MAPTHPGDKMT2A
SCHEMBL25586082 0.83 HDAC6 (0.52) PKMALDH1A1MAPTHPGDKMT2A
SCHEMBL9733462 0.81 GAA (0.48) PKMALDH1A1HPGDKMT2AHSD17B10
SCHEMBL25586594 0.81 HDAC6 (0.50) PKMALDH1A1MAPTHPGDKMT2A
SCHEMBL6404384 0.76 PKM (0.70) PKMALDH1A1MAPTHPGDKMT2A
SCHEMBL28920788 0.72 HTT (0.60) ALDH1A1MAPTKMT2AMEN1ALOX15
SCHEMBL11330915 0.71 PKM (0.45) PKMALDH1A1MAPTHPGDKMT2A
SCHEMBL14112929 0.71 PKM (0.45) PKMALDH1A1MAPTHPGDKMT2A
SCHEMBL23337069 0.71 KLKB1 (0.54) KMT2AMEN1PLA2G10PLA2G2AJAK2
SCHEMBL6265130 0.69 PKM (0.56) PKMALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167129-A1 HETEROCYCLIC AMIDE FOR INHIBITING RIP1 KINASE AND USES THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167129-A1 HETEROCYCLIC AMIDE FOR INHIBITING RIP1 KINASE AND USES THEREOF RIPK1, RIPK3, RIPK4 PKM 1454/4885ALDH1A1 4092/4885MAPT 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.